(Q27851435)

18555254

13 November 2016

title

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu (English)

1 reference

PubMed

13 November 2016

0 references

1 reference

endometrial carcinoma

1 reference

1 reference

Alessandro D Santin

1

0 references

Stefania Bellone

2

0 references

Juan J Roman

3

0 references

Jesse K McKenney

4

0 references

Sergio Pecorelli

International Journal of Gynecology and Obstetrics

5

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

0 references

volume

102

0 references

issue

2

0 references

page(s)

128-31

0 references

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2008.04.008

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2008.04.008

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2008.04.008

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2008.04.008

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2008.04.008

10.1016/J.IJGO.2008.04.008

21 January 2018

Identifiers

DOI

0 references

18555254

1 reference

PubMed

18555254